share

(13R,13Ar)-5,8,13,13A-Tetrahydro-2,3,9,10-Tetramethoxy-13-Methyl-6H-Dibenzo[A,G]Quinolizine CAS NO 6901-07-1


Unit Price:

CAS No.:6901-07-1

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

(13R,13Ar)-5,8,13,13A-Tetrahydro-2,3,9,10-Tetramethoxy-13-Methyl-6H-Dibenzo[A,G]Quinolizine CAS NO 6901-07-1 is a complex, high-purity alkaloid derivative belonging to the quinolizidine class. This compound is valued for its specific stereochemistry and functional groups, making it a critical advanced intermediate in sophisticated organic synthesis. It is primarily sought by pharmaceutical research and development organizations, fine chemical manufacturers, and academic institutions engaged in medicinal chemistry.

Application

  • Pharmaceutical Intermediate: Serves as a key chiral building block for the synthesis of novel therapeutic agents, particularly in central nervous system (CNS) and anti-cancer research.
  • Medicinal Chemistry Research: Used as a reference standard or a core scaffold for structure-activity relationship (SAR) studies and lead optimization.
  • Biochemical Research: Potential application as a ligand or inhibitor in enzymatic studies due to its complex alkaloid structure.
  • Fine Chemical Synthesis: Employed in the multi-step synthesis of complex natural product analogs and other high-value specialty chemicals.
  • Academic & Industrial R&D: A valuable compound for methodological development in asymmetric synthesis and total synthesis projects.

Basic Information

Product Name (13R,13Ar)-5,8,13,13A-Tetrahydro-2,3,9,10-Tetramethoxy-13-Methyl-6H-Dibenzo[A,G]Quinolizine
CAS No. 6901-07-1
Molecular Formula C22H27NO4
Molecular Weight 369.46 g/mol
Synonyms 13-Methyl-2,3,9,10-tetramethoxy-5,8,13,13a-tetrahydro-6H-dibenzo[a,g]quinolizine; (13R,13aR)-5,8,13,13a-Tetrahydro-2,3,9,10-tetramethoxy-13-methyl-6H-dibenzo[a,g]quinolizine; A specific stereoisomer of tetrahydroberberine; Berbine, 2,3,9,10-tetramethoxy-13-methyl-, (13R,13aR)-; Dibenzo[a,g]quinolizine derivative
EINECS Contact for details

Quality Control

Our (13R,13Ar)-5,8,13,13A-Tetrahydro-2,3,9,10-Tetramethoxy-13-Methyl-6H-Dibenzo[A,G]Quinolizine is produced under strict quality management systems. Every batch undergoes comprehensive analytical testing, including chiral purity verification, to ensure identity, potency, and purity meet the stringent requirements for research and synthesis. Certificates of Analysis (COA) detailing specific results for each parameter are available upon request.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (typically 15-25°C). The container should be kept in a well-ventilated area and protected from moisture.

Specification

Item Specification
Appearance White to off-white crystalline powder
Identification (IR) Conforms to structure
Assay (HPLC) ≥ 98.0%
Chiral Purity (Chiral HPLC) ≥ 99.0%
Loss on Drying ≤ 0.5%
Residue on Ignition ≤ 0.1%
Heavy Metals ≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

Why choose US

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.